Searched for
EMCURE INTERNATIONAL BUSINESS
Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....- DRL, Emcure get approval to make breakthrough HIV drugIndia's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for l...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
- Emcure Pharma shares in focus after GST Department conducts search at Mumbai officesEmcure Pharmaceuticals' shares could see action following a Goods and Services Tax search at its Mumbai offices. The inspection concluded t...
- Stocks in news: RIL, Tata Power, JSW Energy, HCL Tech, Inox GreenIndian markets climbed for a sixth day, with Nifty nearing 26,013. Investors watch global cues amid US market volatility. RIL's beauty arm ...
- Emcure Pharma Q2 profit rises 25%, revenue up 13% on broad-based growthPune-based Emcure Pharmaceuticals reported a 13.4% year-on-year rise in consolidated revenue to ₹2,270 crore in the September quarter, supp...
- Emcure Pharmaceuticals reports 41% surge in Q1 net profit driven by strong domestic and international growthEmcure Pharmaceuticals reported a strong first quarter with a 41% increase in net profit, reaching Rs 215 crore, and a 16% rise in revenue ...
- Stocks in news: Vedanta, RBL Bank, Bajaj Finance, RIL, MaricoMarkets experienced volatility on the weekly expiry day, closing marginally lower amidst ongoing consolidation. Vedanta reported strong Q1F...
- Emcure Pharmaceuticals Q4 Results: Profit surges 63% YoY on strong domestic and international growthEmcure Pharmaceuticals reported a 63% YoY rise in Q4 net profit to Rs 197 crore, driven by strong domestic and international growth. EBITDA...
- Emcure Pharma Q3 net profit rises 30% YoY to Rs 156 croreEmcure Pharmaceuticals on Thursday reported a 30.3% year-on-year (YoY) increase in net profit to Rs.156 crore in Q3FY25 led by strong perfo...
- Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stockDriven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal chall...
- Emcure Pharma Q2 Results: Net profit rises 38% to Rs 202 crore, revenue jumps 20%Emcure Pharmaceuticals reported a 38.2% YoY rise in Q2FY25 net profit to Rs 202 crore, driven by strong domestic and international sales. R...
- Emcure Q1 Results: Net profit rises 8.2% to Rs 153 crore, revenue up 16%Emcure Pharmaceuticals saw an 8.2% rise in net profit for Q1FY25, reaching Rs 153 crore due to strong sales in India and abroad. Revenue fr...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- Emcure to soon file papers for Rs 4,000 crore IPOThe IPO will consist of a primary issue and offer for sale from its promoter Satish Mehta and existing investor Bain Capital which acquired...
- PEs in talks for Emcure stake; promoters eye $2 billion valuationJM Financial is advising the company for the stake sale.
- Emcure Pharmaceuticals acquires Canadian company and its marketing arm MarcanMarcan Pharma has over 60 approved products that are mainly available via McKesson and Kohl & Frisch, among other wholesalers, it claimed.
- MS Dhoni to sell health drink, energy bars in partnership with Emcure PharmaceuticalsRhiti Sports, a firm closely associated with Indian cricket captain MS Dhoni, is venturing into health food segment in partnership with Pun...
- Apax, KKR in talks to acquire Blackstone stake in EmcureHealthcare is 1 of the 5 sectors in which Apax Partners invests globally, besides technology & telecom, retail & consumer, media, financial...
Load More
